Increased risk of diabetes in patients with anxiety disorders: A population-based study

Journal of Psychosomatic Research

Volumn 86, Issue , 2016, Pages 47-52

  Chien, I Chia ^a,b   Lin, Ching Heng ^c  

^a Ministry of Health and Welfare   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Anxiety disorders; Diabetes; National Health Insurance; Prevalence; Taiwan

Indexed keywords

ANTIDEPRESSANT AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DRUG USE; FEMALE; HEALTH INSURANCE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL HEALTH INSURANCE; POPULATION RESEARCH; PREVALENCE; RURAL AREA; SUBURBAN AREA; TAIWAN; URBAN AREA; YOUNG ADULT; ADOLESCENT; ANXIETY DISORDERS; CHEMICALLY INDUCED; FACTUAL DATABASE; HEALTH SURVEY; HYPERLIPIDEMIAS; PROCEDURES; PSYCHOLOGY; RANDOMIZATION; RISK FACTOR;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; ANXIETY DISORDERS; DATABASES, FACTUAL; DIABETES MELLITUS; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RANDOM ALLOCATION; RISK FACTORS; YOUNG ADULT;

EID: 84969610692     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2016.05.003     Document Type: Article

References (36)

1. Murray C.J.L., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349:1498-1504.
2. Greenberg P.E., Sisitsky T., Kessler R.C., Finkelstein S.N., Berndt E.R., Davidson J.R., et al. The economic burden of anxiety disorders in the 1990s. J. Clin. Psychiatry 1999, 60:427-435.
3. Kessler R.C., Ormel J., Demler O., Stang P.E. Comorbid mental disorders account for the role impairment of commonly occurring chronic physical disorders: results from the National Comorbidity Survey. J. Occup. Environ. Med. 2003, 45:1257-1266.
4. Roy-Byrne P.P., Davidson K.W., Kessler R.C., Asmundson G.J., Goodwin R.D., Kubzansky L., et al. Anxiety disorders and comorbid medical illness. Gen. Hosp. Psychiatry 2008, 30:208-225.
5. Bowen R.C., Senthilselvan A., Barale A. Physical illness as an outcome of chronic anxiety disorders. Can. J. Psychiatr. 2000, 45:459-464.
6. Muller J.E., Koen L., Stein D.J. Anxiety and medical disorders. Curr. Psychiatry Rep. 2005, 7:245-251.
7. Weiss T., Skelton K., Phifer J., Jovanovic T., Gillespie C.F., Smith A., et al. Posttraumatic stress disorder is a risk factor for metabolic syndrome in an impoverished urban population. Gen. Hosp. Psychiatry 2011, 33:135-142.
8. Farvid M.S., Qi L., Hu F.B., Kawachi I., Okereke O.I., Kubzansky L.D., et al. Phobic anxiety symptom scores and incidence of type 2 diabetes in US men and women. Brain Behav. Immun. 2014, 36:176-182.
9. Sanna L., Stuart A.L., Pasco J.A., Kotowicz M.A., Berk M., Girardi P., et al. Physical comorbidities in men with mood and anxiety disorders: a population-based study. BMC Med. 2013, 10.1186/1741-7015-11-110.
10. Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. J. Psychosom. Res. 2007, 62:31-38.
11. Hasan S.S., Clavarino A.M., Mamun A.A., Kairuz T. Anxiety symptoms and the risk of diabetes mellitus in Australian women: evidence from 21-year follow-up. Public Health 2016, 130:21-28.
12. Butnoriene J., Bunevicius A., Norkus A., Bunevicius R. Depression but not anxiety is associated with metabolic syndrome in primary care based community sample. Psychoneuroendocrinology 2014, 40:269-276.
13. Smith K.J., Béland M., Clyde M., Gariépy G., Pagé V., Badawi G., et al. Association of diabetes with anxiety: a systematic review and meta-analysis. J. Psychosom. Res. 2013, 74:89-99.
14. King H., Aubert R.E., Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998, 21:1414-1431.
15. Chou P., Li C.L., Kuo H.S., Hsiao K.J., Tsai S.T. Comparison of the prevalence in two diabetes surveys in Pu-Li, Taiwan, 1987-1988 and 1991-1992. Diabetes Res. Clin. Pract. 1997, 38:61-67.
16. Hwu H.G., Yeh E.K., Chang L.Y. Prevalence of psychiatric disorders in Taiwan defined by the Chinese diagnostic interview schedule. Acta Psychiatr. Scand. 1989, 79:136-147.
17. Chien I.C., Chou Y.J., Lin C.H., Bih S.H., Chou P. Prevalence of psychiatric disorders among national health insurance enrollees in Taiwan. Psychiatr. Serv. 2004, 55:691-697.
18. Chien I.C., Hsu J.H., Lin C.H., Bih S.H., Chou Y.J., Chou P. Prevalence of diabetes in patients with schizophrenia in Taiwan: a population-based National Health Insurance study. Schizophr. Res. 2009, 111:17-22.
19. Chinese Hospital Association ICD-9-CM English-Chinese Dictionary 2000, Chinese Hospital Association Press, Taipei.
20. Wu E.L., Chien I.C., Lin C.H. Increased risk of hypertension in patients with anxiety disorders: a population-based study. J. Psychosom. Res. 2014, 77:522-527.
21. Chien I.C., Wu E.L., Lin C.H., Chou Y.J., Chou P. Prevalence of diabetes in patients with major depressive disorder: a population-based study. Compr. Psychiatry 2012, 53:569-575.
22. Wu E.L., Chien I.C., Lin C.H., Chou Y.J., Chou P. Increased risk of hypertension in patients with major depressive disorder: a population-based study. J. Psychosom. Res. 2012, 73:169-174.
23. Chien I.C., Lin C.H., Chou Y.J., Chou P. Increased risk of hyperlipidemia in patients with major depressive disorder: a population-based study. J. Psychosom. Res. 2013, 75:270-274.
24. Chien I.C., Hsu J.H., Bih S.H., Lin C.H., Chou Y.J., Lee C.H., et al. Prevalence, correlates, and disease patterns of antipsychotic use in Taiwan. Psychiatry Clin. Neurosci. 2008, 62:677-684.
25. Tyrer P., Baldwin D. Generalised anxiety disorder. Lancet 2006, 368:2156-2166.
26. Curtis B.M., O'Keefe J.H. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin. Proc. 2002, 77:45-54.
27. Lemche A.V., Chaban O.S., Lemche E. Trait anxiety but not state anxiety level associates with biomarkers for hypertension in the metabolic syndrome. Psychophysiology 2016, 10.1111/psyp.12623.
28. Citrome L., Jaffe A., Levine J., Allingham B., Robinson J. Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients. Psychiatr. Serv. 2004, 55:1006-1013.
29. Andersohn F., Schade R., Suissa S., Garbe E. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am. J. Psychiatry 2009, 166:591-598.
30. Aronne L.J., Segal K.R. Weight gain in the treatment of mood disorders. J. Clin. Psychiatry 2003, 64:22-29.
31. Dinca-Panaitescu S., Dinca-Panaitescu M., Bryant T., Daiski I., Pilkington B., Raphael D. Diabetes prevalence and income: results of the Canadian Community Health Survey. Health Policy 2011, 99:116-123.
32. Saydah S., Lochner K. Socioeconomic status and risk of diabetes related mortality in the U.S. Public Health Rep. 2010, 125:377-388.
33. Baptista T. Mechanisms of weight gain induced by antipsychotic drugs. J. Clin. Psychiatry 2002, 63:245-246.
34. Newcomer J.W., Haupt D. The metabolic effects of antipsychotic medications. Can. J. Psychiatr. 2006, 51:480-491.
35. Crawford A.G., Cote C., Couto J. Prevalence of obesity, type II diabetes mellitus, hyperlipidemia, and hypertension in the United States: findings from the GE Centricity Electronic Medical Record database. Popul. Health Manag. 2010, 13:151-161.
36. Lin C.C., Lai M.S., Syu C.Y., Chang S.C., Tseng F.Y. Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J. Formos. Med. Assoc. 2005, 104:157-163.